TickerGuard
Buy Day today: Poor (44) Weak market breadth · no major macro event
PBLS

Parabilis Medicines, Inc.

Healthcare · Biotechnology

28.50$ +0.1% vs. previous close Closing price · As of: Nov 16, 2026

Statements

Income Statement

Parabilis Medicines, Inc. (PBLS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 0.1 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement PBLS
Line item Q1 25 Q2 25 Q1 26 Q2 26
0.0 0.0 0.0 0.1
– 0.6 – –
– -0.6 – 0.1
34 30 38 39
6.3 6.4 9.7 12
40 36 47 51
-40 -37 -47 -51
0.4 0.4 0.3 0.2
-38 -35 -45 -52
-38 -35 -45 -52
-37 -36 -44 -52

Data as of: November 16, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?